Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kanglong Capsule
- Development stage
- Phase 2
- Lead developer
- Hunan Province Changsha Dongya Tumor Prevention and Treatment Research Institute
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Kanglong Capsule is a Traditional Chinese Medicine (TCM) preparation developed by the Hunan Province Changsha Dongya Tumor Prevention and Treatment Research Institute for the treatment of hepatocellular carcinoma (HCC). The formulation is designed to inhibit tumor progression through multiple pathways, including the induction of apoptosis in malignant hepatocytes and the suppression of tumor-associated angiogenesis. In clinical settings within China, it is frequently administered as an oral adjuvant to Transarterial Chemoembolization (TACE), where it has demonstrated potential in improving patient survival rates, enhancing immune function, and mitigating the adverse effects of chemotherapy. As a multi-component herbal therapy, its efficacy is attributed to the synergistic action of various phytochemicals that modulate the tumor microenvironment and inhibit the expression of pro-angiogenic factors.
- Brand names
- Kanglong Capsule
- Other names
- Kanglong Jiaonang抗隆胶囊
02
Targets
BAX (Apoptosis regulator BAX)VEGFA (Vascular endothelial growth factor A)
Beyond the preview
Go deeper on Kanglong Capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kanglong Capsule.